
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
By Scott Kanowsky Investing.com -- AstraZeneca PLC (LON:AZN) has agreed to acquire U.S. biotech CinCor Pharma Inc (NASDAQ:CINC) in a deal worth as much as $1.8 billion, as the Anglo-Swedish...
By Peter Nurse Investing.com - European stock markets edged higher Monday, with sentiment boosted by China’s decision to fully reopen its borders as well as stronger-than-expected German industrial...
AstraZeneca AZNUK:AZN said Thursday that the Food and Drug Administration is no longer allowing healthcare providers to prescribe Evusheld, a therapy authorized for pre-exposure prophylaxis of...
OCALA, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat...
The FDA approved AstraZeneca Plc's (NASDAQ: AZN) Airsupra, formerly PT027, as the first and only rescue medication for as-needed use to reduce the risk of asthma exacerbations. The drug is only...
AstraZeneca AZNUK:AZN said Wednesday that the Food and Drug Administration approved a new therapy that can be used to treat or prevent bronchoconstriction in adults with asthma. Thee company said...
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire to CinCor Pharma Inc (NASDAQ: CINC) for $26.00 per share in cash plus a contingent value right of $10.00 per share in cash payable upon a specified...
European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review